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20850 (e-mail: denise.dougherty@ahrq.hhs.gov).ACADEMIC PEDIATRICS 2011;11:S91–S94WE WERE DELIGHTED to see passage of the Children’s
Health Insurance Program Reauthorization Act of 2009
(CHIPRA).1 CHIPRA provides unprecedented opportuni-
ties and resources for the US Department of Health and
Human Services and its components to work with a broad
range of stakeholders to improve the quality of health care
delivered to the nation’s children. The initial focus is on the
almost 40 million children enrolled in Medicaid and CHIP,
and the goal is better care for all children.
In this commentary, we use concepts of the translational
continuum from basic biomedical research to optimal
population health (Figure).2–8 We note the contributions
that CHIPRA makes to overcoming what we have
characterized as the third translational block—between
sufficient knowledge of clinical effectiveness and reliable
delivery of safe and effective services at every patient’s
bedside—and suggest that for substantial improvements
to be made in children’s health care and health, additional
attention must be paid to all components of the
translational continuum.THE TRANSLATIONAL CONTINUUM
As shown in the Figure, basic biomedical knowledge is
considered the foundation of health care delivery and
optimal child health. As an example of the priority put on
basic bioscience, there is much work underway to under-
stand human genetics, believed to be the most critical
building blocks of human health.9 However, as is now
familiar to the clinical research and health care delivery
communities, basic knowledge aboutmechanisms of action
in the human body and brain does not by itself improve
health. That basic information must be used to develop
efficacious and effective clinical and public health interven-
tions (eg, drugs, devices, and patient behavior change inter-
ventions). It is now well accepted that numerous factors
inhibit the translation of knowledge from basic biomedical
research into clinical efficacy trials, and from clinical
efficacy trial findings to clinical effectiveness research
and results. These factors continue to be characterizedACADEMIC PEDIATRICS
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S91and are commonly grouped into so-called “translational
blocks” 1 and 2.4,5
Despite work under way to overcome translational
challenges in blocks 1 and 2, greater attention to clinical
efficacy and effectiveness research will not be enough
to get effective care reliably to all Americans at points
of care.10,11 We have characterized this new set of
challenges by using the term the third translational block
and suggested approaches to overcoming this third set of
challenges.3 These approaches include increased support
for a different kind of research and evaluation (ie, under-
standing and testing health care quality improvement12),
as well as nonresearch endeavors, including enhanced
leadership and teamwork for health care quality improve-
ment, and greater attention to monitoring health care
quality and disparities in quality and taking strong action
to reduce gaps.
In this commentary, we suggest that the quality portions
of CHIPRA contribute greatly to overcoming the third
translational block between clinical knowledge and
improved care quality and outcomes, but that to make
even more substantial improvements in children’s health
care and health, more attention to children’s clinical
research is needed. This additional attention may mean
focusing additional resources on the more traditional first
and second translational blocks.CHIPRA MAKES HEADWAY TOWARD
OVERCOMING THE THIRD
TRANSLATIONAL BLOCK
As noted above, crossing the third translational block
requires leadership and teamwork, quality monitoring,
and action to address gaps in quality, including disparities
in care. Congress demonstrated leadership by writing and
passing CHIPRA, which in turn supports additional leader-
ship and teamwork across the US Department of Health
and Human Services and State Medicaid and CHIP
programs. The CHIPRA focus on measurement and related
reporting1,13,14 is essential for monitoring progress inVolume 11, Number 3S
tion May–June 2011
Figure. Transformation of health care delivery across the translational continuum: research and action. Adapted from Dougherty and
Conway, 20083; Murrillo et al, 20032; Sung et al, 20034; Szilagyi, 2009.6
S92 DOUGHERTY AND CLANCY ACADEMIC PEDIATRICSchildren’s health care quality. CHIPRA also includes
a major quality improvement initiative at the state level,
which focuses on provider-based quality improvement
interventions, testing a model electronic health record
format and other health information technology implemen-
tation, and system-wide changes such as medical home
interventions.14 Findings from these improvement efforts
will be summarized and shared widely.NEED FOR MORE EVIDENCE OF CLINICAL EFFECTIVENESS
OF SERVICES FOR CHILDREN
Despite the attention in CHIPRA to translation 3 activi-
ties, the evidence grading exercise used during identifica-
tion of the initial recommended core set of children’s
health care quality measures provides compelling confir-
mation of the need for activities earlier in the translational
continuum.15 In the end, only 2 initial core CHIPRA
measures were able to be given the highest evidence grade
of A, using as a basis for grading the Oxford Centre for
Evidence Based Medicine.16 Thirteen measures in the
core set received grades of B (including, but not limited
to, prenatal care frequency and timing, low birthweight,
low-risk C-section rates, immunizations, well-child care
visits, developmental screening, chlamydia screening,
pediatric central line associated blood stream infections).
One measure received a grade ofC (emergency department
visits as an indication of poor quality asthma care), and
several measures received D grades (dental treatment,
attention-deficit/hyperactivity disorder follow-up, hemo-
globin A1c testing for children with diabetes). Although
evidence-grading schemes can be controversial, grades
such as these are consistent with the experience of the USPreventive Services Task Force17 findings of Agency for
Healthcare Research and Quality’s (AHRQ) evidence-
based practice center program18 and similar entities and
reviews.19,20 In essence, it is rare to find grade A evidence
in children’s clinical literature, even for services that are
provided every day to tens of millions of children.
Although a lack of evidence does not necessarily mean
that services are not effective, the paucity of high-grade
evidence could cast doubt on the utility of the initial core
set. Therefore, it is critical to take steps to add to the
evidence base.
New efforts are under way that should help build the clin-
ical evidence base in children’s health. Optimally, the new
pediatric focus in the National Institutes of Health–
supported Clinical and Translational Science Awards will
accelerate activities to cross the first translational block—
from basic biomedical science findings to clinical efficacy
research—and beyond.21 Refreshed Better Pharmaceuti-
cals for Children Act activities should also help transform
basic science into child-safe and effective drug treatments.
In federal fiscal years 2009 and 2010 (October 1, 2008 to
September 30, 2010), 42 pediatric-relevant comparative
effectiveness research projects were funded by AHRQ
and National Institutes of Health using American Recovery
and Revitalization Act funds, for a total of $7.6 million.22
Projects focus on a variety of topics (eg, attention-deficit
hyperactivity disorder, HIV prevention, reproductivemedi-
cine, autism spectrum disorders, cleft lip and palate, and
juvenile idiopathic arthritis). Patient-Centered Outcomes
Research initiatives under the Patient Protection and
Affordable Care Act of 2010 may help address the second
translational block through even more focus on high-
priority areas for comparative effectiveness research.23,24
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assessment in children’s health care is the increasing
consideration of methods and infrastructures other than
the randomized controlled trial, given the challenges
inherent in children’s clinical research (eg, small numbers
of children with specific conditions).25 For example, regis-
tries are being created to track children identified through
newborn screening.26 Carefully done, such registries can
identify patterns and details of care for children along
with detailed child characteristics, to begin to assess which
treatments may be most effective for which children.
Randomized controlled trials can then be carefully de-
signed to comparatively test themost promising treatments.
AHRQ is funding several child-relevant health care quality
improvement research projects to identify the “how” and
“why” of effective implementation.27
Addressing whether existing resources will be enough to
address the gaps in children’s health care science that
impede improving children’s health outcomes is beyond
the scope of this commentary. Given longstanding concerns
about the resources available for pediatric research,28–30
more in-depth analysis could be helpful and lead to a prior-
itized clinical research agenda in child health.6 Setting
research priorities can be a difficult topic given the variety
of criteria, but several approaches are emerging and could
be adapted for use within the translational continuum.
For example, the AHRQ National Advisory Council on
Healthcare Quality and Research Subcommittee on
Children’s Healthcare Quality Measures for Medicaid and
CHIP (SNAC) agreed on criteria for the importance of
child health topics for quality measurement, and the
SNAC itself identified important areas for future measure
development.14 The article by Dougherty and colleagues31
in this issue provides additional detail on prevalence and
costs for selected conditions that may be useful in setting
priorities. More high-priority areas are forthcoming
from analysis of the request for public input posted in
December 2010.32BEYOND A LINEAR APPROACH TO CROSSING
THE QUALITY CHASM
It is important to note that although it is convenient to
portray the translational continuum as a pyramid33 or time-
line (Figure), progress is never linear. The absence of
knowledge of causation need not impede efforts to test
promising clinical interventions and to apply knowledge
broadly as soon as it is appropriate. For example, the causes
of asthma, premature birth, low birthweight, childhood
obesity, and adolescent depression are not yet fully known,
but there is evidence of the effectiveness of some preven-
tion and treatment approaches for these conditions. The
need for better evidence should not slow down efforts to
implement what is known to work now. More effort could
also be put into developing and spreading effective health
care quality improvement strategies to bring effective clin-
ical interventions to more children.34
We believe that to motivate additional efforts to improve
health care quality for children attention must be paid tothe following: 1) simultaneously overcoming the first and
second translation blocks that hinder movement from basic
biomedical discovery to clinical efficacy, and clinical effi-
cacy to clinical effectiveness; and 2) simultaneously over-
coming the third translational block between demonstrated
effectiveness and reliable delivery to every child who can
benefit from the intervention. In addition, as shown in the
Figure, these activities should not be linear—we need contin-
uous feedback and feed forward loops across the continuum.
Without a solid clinical evidence base, providers, health
plans, states, and families may be unlikely to take the trouble
to engage inmeasurement and participate in quality improve-
ment initiatives. Without focused attention to activities
beyond basic and clinical research, the fruits of such research
will wither, and childrenwill never receive the high quality of
care or health outcomes envisioned by those who drafted the
CHIPRA legislation. Without continuous productive interac-
tions back and forth across the continuum, our efforts will
continue to be siloed and progress will be slow.REFERENCES
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